LDC1267
CAS No. 1361030-48-9
LDC1267 ( LDC1267 | LDC-1267 | LDC 1267 )
产品货号. M17256 CAS No. 1361030-48-9
LDC1267 是一种极好的特异性 TAM(Tyro3、Axl 和 Mer)激酶抑制剂,针对 Mer(IC50<5 nM)、Tyro3(IC50=8 nM)和 Axl(IC50=29 nM)。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥458 | 有现货 |
|
| 5MG | ¥781 | 有现货 |
|
| 10MG | ¥1264 | 有现货 |
|
| 25MG | ¥2260 | 有现货 |
|
| 50MG | ¥3376 | 有现货 |
|
| 100MG | ¥4707 | 有现货 |
|
| 500MG | ¥9810 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥938 | 有现货 |
|
生物学信息
-
产品名称LDC1267
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述LDC1267 是一种极好的特异性 TAM(Tyro3、Axl 和 Mer)激酶抑制剂,针对 Mer(IC50<5 nM)、Tyro3(IC50=8 nM)和 Axl(IC50=29 nM)。
-
产品描述LDC1267 is a potent and selective TAM kinase inhibitor. LDC1267 displays lower activity against Met, Aurora B, Lck, Src, and CDK8. LDC1267 markedly reduced murine mammary cancer and melanoma metastases dependent on NK cells. The TAM tyrosine kinase receptors Tyro3, Axl and Mer (also known as Mertk) were identified as ubiquitylation substrates for Cbl-b. Treatment of wild-type NK cells with a newly developed small molecule TAM kinase inhibitor conferred therapeutic potential, efficiently enhancing anti-metastatic NK cell activity in vivo.
-
体外实验——
-
体内实验Animal Model:C57BL/6J wild type mice (8-12 weeks old syngeneic bearing B16F10 cells) Dosage:20mg/kg Administration:Intraperitoneal injection; every 12 hours for 14 daysResult:Markedly reduced metastatic spreading of melanomas.
-
同义词LDC1267 | LDC-1267 | LDC 1267
-
通路Cell Cycle/DNA Damage
-
靶点PLK
-
受体AXL| Mer| Tyro3
-
研究领域Inflammation/Immunology
-
适应症——
化学信息
-
CAS Number1361030-48-9
-
分子量560.55
-
分子式C30H26F2N4O5
-
纯度>98% (HPLC)
-
溶解度DMSO : 50 mg/mL. 89.20 mM; H2O : < 0.1 mg/mL
-
SMILESc1(c(cc2c(c1)c(ccn2)Oc1ccc(cc1F)NC(=O)c1nn(cc1OCC)c1ccc(cc1C)F)OC)OC
-
化学全称N-[4-[(6,7-dimethoxy-4-quinolyl)oxy]-3-fluoro-phenyl]-4-ethoxy-1-(4-fluoro-2-methyl-phenyl)pyrazole-3-carboxamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Paolino M, et al. Nature. 2014, 507(7493), 508-512.
产品手册
关联产品
-
GW843682X
GW843682X 是 PLK1 和 PLK3 的选择性 ATP 竞争性抑制剂,IC50 分别为 2.2 nM 和 9.1 nM,并且对 ~30 种其他激酶的选择性也超过 100 倍。
-
GSK-461364
一种有效、选择性和可逆的 ATP 竞争性 PLK1 抑制剂,Ki 为 2.2 nM。
-
5-ETHYL-4,5,6,7-TETR...
5-ETHYL-4,5,6,7-TETRAHYDRO-THIAZOLO[5,4-C]PYRIDIN-2-YLAMINE 靶向 PLK1。
021-51111890
购物车()
sales@molnova.cn

